Metadata
- Name
- Safety and Efficacy of Lotemax Versus FML in Subjects Undergoing PRK for the Correction of Mild to Moderate Myopia, 3- Month Follow-up Study
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT02974387
- Description
- STUDY OBJECTIVE: To evaluate and compare the safety and efficacy of (corneal Wound Healing
and Intraocular Pressure) Fluorometholone and Loteprednol after photorefractive keratectomy
(PRK) surgery.
OVERALL STUDY DESIGN: Structure: Single-center, randomized, single blinded, contralateral
(one eye receives FML, one eye Lotemax) Treatment Group: Patients will be randomized to the
eye and will receive FML in one eye, Lotemax in contralateral eye Duration: 3 months
Dosage/Dose Regimen: All patients will receive each one of the steroid agents 4 x a day for
one month, 3 x a day for one month and 2 x a day for one month Study medication will be
administered to the randomized eye through post op days according to mention protocol. Visit
Schedule: baseline-screening, postop days 1, 7, 30 and then month 3th (through corneal
re-epithelialization). - Data or Study Types
- clinical trial
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2016
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT02974387
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT02974387